Introduction
The Pebpb2/Cbfb gene encodes the b subunit of a herodimeric transcription factor PEBP2/CBF (Ogawa et al., 1993a; Wang et al., 1993) . The b polypeptide which is devoid of a DNA binding activity, dimerizes with the a subunit and enhances its DNA binding anity. The biological signi®cance of Pebpb2/Cbfb is amply shown, ®rstly by its involvement in one subtype of human acute myeloid leukemia (Liu et al., 1993) . The Pebpb2/Cbfb and smooth muscle myosin heavy chain (SMMHC) genes are fused due to a chromosomal inversion 16 (p13q22) and a chimeric transcript is synthesized from the fused gene in leukemic cells. Secondly, recent gene targeting studies including our own have shown that Pebpb2/Cbfb is essential for development of de®nitive hematopoiesis in the murine fetal liver (Sasaki et al., 1996; Wang et al., 1996b ; Niki et al., submitted for publication). The Pebpb2/Cbfb (7/7) embryos do not develop the multipotent hematopoietic progenitors in the liver and die on embryonic day 12.5 (E12.5) probably due to the coincident hemorrhaging into the central nervous system. The almost identical phenotype is observed in the targeting of Aml1/Pebpa2b/Cbfa2 (Okuda et al., 1996; Wang et al., 1996a) , another protooncogene involved in human acute myeloid and lymphoblastic leukemia (Erickson et al., 1992; Golub et al., 1995; Mitani et al., 1994; Miyoshi et al., 1991; Nucifora et al., 1993; Nucifora and Rowley, 1995; Romana et al., 1995; Shurtle et al., 1995) . This gene belongs to a mammalian runt gene family that encode the a subunit of PEBP2/CBF (Bae et al., 1993) . The Runt domain, which is conserved in the polypeptides of the runt family, is responsible for DNA binding activity and heterodimer formation with the b polypeptide (Bae et al., 1994; Kagoshima et al., 1993; Meyers et al., 1993; Ogawa et al., 1993b) .
Although indispensability of Pebpb2/Cbfb in definitive hematopoiesis is established, the targeting studies do not give any information on the possible roles of the gene in the other tissues or cells which develop or dierentiate after E12.5. For example, the skeletal myogenic cells start to dierentiate and mature mainly after E12.5. We are motivated to examine the expression of the PEBP2b/CBFb protein in those cells by the following two observations. Firstly, although the Pebpb2/Cbfb transcripts are detected in all the tissues of adult mice examined by Northern blot analysis Wang et al., 1993) , its expression is particularly abundant in the skeletal muscle (Wang et al., 1993) . Of interest also is another report showing that the amount of the Pebpb2/Cbfb transcripts is increased, although moderately, in the skeletal muscles of adult mice by nerve denervation, suggesting the gene expression to be regulated by electrical activity (Zhu et al., 1994) . The second possibly important element in understanding a physiological role of the PEBP2b/CBFb protein is its subcellular localization in the cell. We previously reported that the PEBP2b/CBFb protein is detected solely in the cytoplasm in cDNA transfected NIH3T3 cells (Lu et al., 1995) . This observation raises the interesting possibility that PEBP2b/CBFb by itself may be a cytoplasmic protein besides as the subunit of a transcription factor functioning in the nucleus. Since there has been no report showing the in vivo expression of PEBP2b/CBFb, it would be preferable to have an idea of the relative amounts of PEBP2b/CBFb in the nucleus and/or in the cytoplasm of cells from tissues. As described in this report, the skeletal myogenic cells were one example that displayed characteristic cytoplasmic and nuclear localization. Based on the rationale described above, we focus in this report our studies on the expression and localization of the PEBP2b/CBFb protein in muscle cell development and describe its nature as a cytoplasmic as well as nuclear protein, whichever stands depending on the cell dierentiation. Our parallel observations that PEBP2b/CBFb was detected to various degrees in various tissues besides the myogenic cells from adult mice as well as from embryos will be described elsewhere (data not shown). The implications of the present observations that are unexpected from the known feature of PEBP2b/CBFb as a subunit of the transcription factor are discussed.
Results

Characterization of the PEBP2b/CBFb antibodies
The anti-PEBP2b/CBFb peptide antibody was prepared in hens using a synthetic oligopeptide that corresponds to the amino-terminal ®fteen amino acid sequence of the PEBP2b/CBFb protein (Ogawa et al., 1993a; Wang et al., 1993) . The Western blot analysis shown in Figure 1 demonstrates that the anti-peptide antibody can recognize PEBP2b/CBFb. The proteins extracted from E15.5 mouse embryos were separated on a SDS-polyacrylamide gel and transferred to the membrane. The blotted ®lter was incubated with the antibody in the absence (lane 1) or presence (lane 2) of an excessive amount of the peptide and processed for immunodetection. Several bands including one that migrated at a postition corresponding to a molecular weight of 22 kilodaltons (kd) were detected by the antibody. Inclusion of the peptide during incubation with the antibody abolished the 22 kd but not the other bands. The 22 kd band comigrates with the authentic PEBP2b/CBFb protein puri®ed from an E. coli lysate (data not shown). Therefore, the anti-peptide antibody can speci®cally recognize PEBP2b/CBFb. Another antibody used was raised in rabbits using as an antigen the intact PEBP2b/CBFb protein puri®ed from an E. coli lysate and has been described previously (Lu et al., 1995) . The protein was extracted from hind limbs of E16.5 mouse embryos (lane 3) or from the thigh muscle of adult mice (lane 4) (note that a higher concentration of gel was used in lane 4). The rabbit antiserum can also detect PEBP2b/CBFb in these tissues by Western blot analysis.
All the immunohistochemical stainings we show in this study are considered to be due to PEBP2b/CBFb protein as judged by the following two criteria. (1) Preincubation of the anti-peptide antibody with an excessive amount of the peptide completely abolished staining. (2) Both the anti-peptide antibody and the antibody raised against the intact PEBP2b/CBFb protein yielded indistinguishable staining patterns. The latter rabbit antiserum appears to recognize an epitope(s) in the PEBP2b/CBFb protein other than the amino-terminal ®fteen amino acid sequence, since the antiserum did not show any reactivity in an enzymelinked immunosorbent assay, using the solidi®ed peptide as an antigen. In addition, preincubation of the rabbit antiserum with an excessive amount of the peptide did not aect the reactivity of the antiserum to the bacterially puri®ed PEBP2b/CBFb protein in Western blot analysis (data not shown).
In the following sections only results obtained using the anti-peptide antibody are shown, but in parallel experiments similar results were obtained using the antibody directed against the PEBP2b/CBFb protein.
Expression of PEBP2b/CBFb in muscle cells from adult mice
When sections of the thigh muscle were taken from adult mice and incubated with the anti-peptide antibody, a characteristic striped staining pattern was observed in the cytoplasm of the muscle ®bers as shown in Figure 2a . This staining disappeared completely when the antibody was preincubated with an excessive amount of the synthetic peptide ( Figure  2b ). The periodicity of the striped staining is roughly every 2 mm along the longitudinal axis of the ®ber. Each muscle ®ber is actually a continuum of fused cells and is therefore multinucleated. A similar periodic staining of PEBP2b/CBFb was also observed in the muscle ®bers from the tongue (Figure 2d ). Myocytes in the heart do not fuse together but are joined tightly end-to-end. Here again, PEBP2b/CBFb appears as (Figure 2c ). The PEBP2b/CBFb staining in the nucleus was below detectable levels in all three muscles. In order to determine the nature of the subcellular structure that showed periodic PEBP2b/ CBFb staining in the muscle ®ber, a double immuno¯uorescent method was employed. Myofibrils were prepared from thigh muscle and incubated with mixtures of the anti-peptide antibody and the anti-a-actinin antibody. The a-actinin molecules are known to be localized on the Z-lines in striated muscles and serve as anchoring molecules for the actin ®laments (Maruyama and Ebashi, 1965; Masaki et al., 1967) . PEBP2b/CBFb and a-actinin immunocomplexes were detected by¯uorescein isothiocyanate (FITC)-conjugated ( Figure 3a ) and rhodamine isothiocyanate (RITC)-conjugated secondary antibodies (Figure 3b ), respectively and the samples were viewed through a confocal laser scanning microscope. A comparison of Figure 3a and b of an identical optical ®eld with appropriate ®lters showed that most of the¯uorescent signal of PEBP2b/CBFb overlapped with that of a-actinin. Colocalization of PEBP2b/CBFb and a-actinin was further con®rmed when the two images in Figure 3a and b were analysed so as to select for only colocalized¯uorescences ( Figure 3c ). These observations indicate clearly that the PEBP2b/CBFb protein is concentrated in or around the Z-line. Since the Zlines are the ®xative sites of actin ®laments, the same double staining of myo®brils was performed again except that the a-actinin antibodies were replaced by RITC-conjugated phalloidin which detect F-actin (Figure 3d ). Figure 3d is a composite image of¯uorescence from FITC and RITC.
Alternate stainings of PEBP2b/CBFb and F-actin are evident, further stressing our original observations that PEBP2b/CBFb is localized on or around the Z-lines.
The localization of PEBP2b/CBFb in skeletal muscle raises the possibility that PEBP2b/CBFb is also expressed in smooth muscle cells. The colon of adult mice was taken as representative of smooth muscle and was immunohistochemically stained by the anti-peptide antibody ( Figure 4 ). Figure 4a represents a lower magni®cation of a transverse section of the colon. Three anatomical regions were densely stained. These correspond to a muscular layer (indicated by an arrowhead), muscle cells scattered in the submucosa (a short arrow) and the muscularis mucosae (a long arrow). The smooth muscle cells distributed in the submucosa were viewed at higher magni®cations and the results are shown in Figure 4b and c. Of interest is the multiple spot staining of PEBP2b/CBFb, in addition to the diuse staining of the cytoplasm. It is dicult though, for the moment, to assign an identity to the substructures that showed multiple spot stainings. The nuclear staining of PEBP2b/CBFb was not detected in the smooth muscle cells.
To verify the expression of Pebpb2/Cbfb in muscles, we performed a Northern blot analysis. RNAs were extracted from the heart, colon and the thigh muscle of adult mice. Poly(A) + RNAs were separated on an agarose gel, blotted onto the membrane ®lter, and the ®lter was probed with a fragment of the Pebpb2 cDNA. As seen in Figure 5 , a typical 3.0 kilobases (kb) transcript of Pebpb2/Cbfb was detected in all three tissues. In the case of thigh muscle, a 2.7 kb transcript was also detected in addition to the 3.0 kb band. The existence of a 2.7 kb transcript in skeletal muscle has Figure 2 Immunodetection of PEBP2b/CBFb in the muscle ®bers isolated from adult mice. Sections of the thigh (a), heart (c) or tongue (d) muscles from adult mice were incubated with the anti-peptide antibody and processed for enzyme-linked immunodetection. In b, the antibody solution was preincubated with an excessive amount of the peptide before use in immunostaining of the thigh muscle. A bar in a indicates 10 mm in length Expression of PEBP2b/CBFb in muscle N Chiba et al also been reported by Wang et al. (1993) . Therefore, the Pebpb2/Cbfb gene is indeed transcribed in the tissues that we examined by immunohistology.
Expression of PEBP2b/CBFb in embryonic developing muscles
So far, we have demonstrated that the PEBP2b/CBFb protein colocalizes with the a-actinin molecules on or around the Z-lines of skeletal muscle ®bers, and that it is concentrated as multiple spots in the smooth muscle cells of the colon. These results were obtained by staining the tissues taken from adult mice. To extend these data, we examined the expression pattern of PEBP2b/CBFb during muscle development in embryos as well as in newborn mice. In skeletal muscle, Z-line structures become regularly aligned during a late stage of embryonic development. Like in the case of adult mice, we found that the PEBP2b/CBFb protein is present as periodic stripes in the muscle cells of the thigh, tongue and heart from newborn mice (data not shown).
The skeletal myogenic cells in E16.5 embryos are known to possess sarcomeric structures but are not suciently matured so as to have regularly aligned actin-myo®brils or Z-line structures. As a differentiation stage they correspond to the myotubes. The myotubes are generated by the fusion of a number of cells and possess multiple nuclei. PEBP2b/CBFb was detected in abundance in the cytoplasm of myotubes distributed in the intercostal region (Figure 6a and b) . The entire cytoplasm was stained and no particular subcellular structure was immediately evident. There was also signi®cant staining of the nuclei (Figure 6c ). In muscle development, this was the only stage at which nuclear staining of PEBP2b/CBFb was observed. Why only a subfraction of the nuclei were positive for PEBP2b/CBFb is not known at present. To con®rm the subcellular localization of PEBP2b/CBFb, we prepared primary tissue culture from a pectoris muscle of E11.5 chick embryos that correspond to murine E14.5 in developmental stage. Two days after plating, the cells were harvested and fractionated. Western blot analysis revealed the PEBP2b/CBFb protein in the cytoplasmic as well as nuclear fractions (NC and MS, unpublished observation) . In contrast to the high level of accumulation of the PEBP2b/CBFb protein in the myotubes in E16.5 mouse embryos, cytoplasmic staining of PEBP2b/ CBFb was relatively low in the myocytes found in the same intercostal region from E13.5 embryos (Figure 6d and e) . The myocytes at this stage are elongated and aligned side by side along a longitudinal axis. With time, these cells are prone to fuse. Dierentiation of the myogenic cells proceeds more Figure 3 Double immuno¯uorescence of the PEBP2b/CBFb and a-actinin or F-actin molecules in the myo®brils prepared from thigh muscles. In a and b, the myo®brils were incubated with mixtures of the anti-peptide antibody and the anti-a-actinin antibody. PEBP2b/CBFb (a) and a-actinin (b) were detected by the FITC-or RITC-conjugated secondary antibody, respectively. c is an image analysed so as to pick up only¯uorescence that is colocalized in a and b. In d, the myo®brils were incubated with the anti-peptide PEBP2b/CBFb antibody followed by the FITCconjugated secondary antibody and RITC-phalloidin. d is a composite image of¯uorescence from FITC and RITC Figure 4 Immunodetection of PEBP2b/CBFb in the colon from adult mice. Sections of colon were incubated with the anti-peptide antibody and processed for enzyme-linked immunodetection. a, b and c represent lower, moderate and higher magni®cations of the tissues and/or the cells, respectively. In a, the anatomy of colon is indicated as follows; M, mucosa; long arrow, muscularis mucosae; short arrow, submucosa; arrowhead, muscularis. b represents smooth muscle cells found in the submucosal tissue and c is an enlarged view of these cells
Expression of PEBP2b/CBFb in muscle N Chiba et al slowly in the tongue muscle ( Figure 7 ). In E16.5 embryos the myogenic cells in the tongue were still at the stage of aligned myocytes and showed relatively weak staining of PEBP2b/CBFb (Figure 7a and b) . On the other hand, the undierentiated myoblasts which are distributed in a random orientation in the tongue from E13.5 embryos do not express a detectable amount of the PEBP2b/CBFb protein (Figure 7c and d).
Taken together, the above observations suggest that the degree of PEBP2b/CBFb protein expression is dependent on the dierentiation stage of the skeletal myogenic cells; levels of expression ranged from undetectable in the undierentiated myoblasts to moderate levels in the elongated and aligned myocytes, and to abundant accumulation of the protein in the myotubes. These conclusions remain qualitative in nature, since distinct and separate sections were compared. We therefore attempted to verify the above conclusions by examining within a single section the expression of PEBP2b/CBFb (Figure 8) . The myogenic cells located in the distal and proximal portion of a limb re¯ect dierent stages of development. Figure 8a represents a limb from E16.5 embryos. It can be readily seen that the fully dierentiated myotubes are densely stained for PEBP2b/CBFb (arrowhead), whereas the aligned myocytes are moderately positive (arrow). A similar situation can be seen in a limb taken from E13.5 embryos (Figure 8b ). The cells located in a distal part (arrowheads) some of which are known to be positive for a myogenic transcription factor, MyoD (Bober et al., 1994) are totally negative for PEBP2b/ CBFb staining. The more or less dierentiated myocytes in a proximal part (arrow), on the other hand, have become positive for immunostaining. These observations in sections taken from the limb therefore con®rm the dierentiation-dependent accumulation of the PEBP2b/CBFb protein in the cytoplasm of the skeletal myogenic cells.
The expression pattern of the PEBP2b/CBFb protein in the embryonic heart and digestive tract (Figure 9 ) displays a dierent feature from that in the skeletal myogenic cells. In E9.5 embryos, the heart was found to be already strongly positive for PEBP2b/CBFb staining ( Figure 9a ) and this staining in heart persisted through until birth (data not shown). Interestingly, when viewed at a higher magni®cation (Figure 9b ), only the dierentiated cardiac myocytes (indicated by an arrow) are positive for PEBP2b/CBFb in the cytoplasm. No staining was detected in the jelly-like mesenchymal or stromal cells¯oating in the cavity (arrowhead). The expression of the PEBP2b/CBFb protein in an embryonic digestive tract was also examined. Figure 9c is an example from a section of E13.5 embryos. It can be seen that the muscularis mucosae (arrow) is positive for the PEBP2b/CBFb protein. A similar type of staining pattern of the digestive tract persisted through until birth (data not shown). It appears, therefore, that there is no appreciable change in the level of PEBP2b/CBFb expression in the cardiac and digestive tract muscle cells throughout development examined in this study. This is in contrast to the case of the cells from the skeletal muscle lineage.
We ®nally con®rmed the expression of the Pebpb2/ Cbfb gene in embryos by in situ hybridization histochemistry. Digoxigenin-labeled RNA transcribed from a PEBP2b cDNA fragment was used as a hybridization probe. The antisense probe reveals a signal in the myocytes of limbs from E15.5 embryos and in the heart of E12.5 embryos, whereas the sense probe does not (data not shown).
Discussion
PEBP2b/CBFb expression in muscle development
The myogenic cells proceed through several stages of dierentiation and maturation in skeletal muscle development (Blau et al., 1985) . We demonstrated that PEBP2b/CBFb is expressed and accumulated in the cytoplasm in a step-wise fashion depending on the dierentiation stage of the skeletal myogenic cells. This occurs roughly in parallel with the expression of cytoskeletal proteins such as actin and myosin (Devlin and Emerson, 1978; Lyons et al., 1990; Sassoon et al.,
-3.0 -2.7 colon heart thigh muscle Figure 5 Northern blot analysis of the Pebpb2/Cbfb transcripts in tissues taken from adult mice. The poly(A) + RNAs isolated from the indicated tissues were separated on an agarose gel and transferred to the membrane. The ®lter was probed with the labeled pebpb2 cDNA fragment. The sizes of the transcripts are indicated in kilobases Expression of PEBP2b/CBFb in muscle N Chiba et al 1988). The cytoplasmic staining of PEBP2b/CBFb in the myotubes does not show any apparent structural speci®city for the moment. In this respect, it should be recalled that the actin-®laments and Z-lines are not yet organized into easily recognizable, regularly aligned myo®brils at the myotube stage.
Once the muscle ®bers were established, PEBP2b/ CBFb was detected as periodic stripes along the longitudinal axis. The structures represent Z-lines themselves or their vicinity, since a double-immunouorescent staining showed colocalization of the PEBP2b/CBFb and a-actinin molecules. It must be mentioned also that a structure called costamere links the cell membrane and Z-line and encircles the myo®brils at the Z-line. This structure contains various cytoskeletal proteins including talin, spectrin, ankyrin, desmin, vimentin and dystrophin (Morris and Fulton, 1994) . Further analysis will be required to determine the ultrastructural localization of PEBP2b/ CBFb and whether PEBP2b/CBFb has an association with a-actinin or some other cytoskeletal molecules. As an example of colocalization and functional association with a-actinin, we may refer phosphatidylinositol 4,5-bisphosphate (PIP 2 ). This molecule, by binding to aactinin, enhances its activity to gelate F-actin (Fukami et al., 1992) .
PEBP2b/CBFb showed strongly positive staining in the heart of E9.5 embryos. Since dierentiation of the cardiac myocytes had been almost completed by that period, it was dicult to analyse exactly whether the expression of PEBP2b/CBFb similarly increases depending on dierentiation. Another caveat to be noted will be to see whether there may be a dysfunction or not in the heart of Pebpb2/Cbfb(7/7) embryos, although an initial inspection did not reveal a gross morphological abnormality (MN and MS, unpublished observation).
PEBP2b/CBFb as a cytoplasmic as well as nuclear protein in vivo PEBP2b/CBFb was originally identi®ed as a non-DNA binding subunit of the heterodimeric transcription factor, PEBP2/CBF (Ogawa et al., 1993a; Wang et al., 1993) . Therefore we initiated the present immunohistochemical study with the expectation that PEBP2b/ CBFb would be mostly present in the nucleus. This turned out not to be the case as described in the text. A fraction of the nuclei were, however, indeed positive for PEBP2b/CBFb staining in the multinucleated myotubes (Figure 6c) . We previously reported that in NIH3T3 cells only transfected with the Pebpb2/Cbfb- vector, the b protein was found to be located in the cytoplasm. However, it was found to relocate to the nucleus if the cells were co-transfected with the Pebpb2/ Cbfb-and truncated form of pebpa2-vectors (Lu et al., 1995) . If the expression of the a protein is the case in the nuclei of myotubes, it would be reasonable to speculate that the b subunit functions in the nucleus as a part of the transcription factor at a limited stage of myogenic dierentiation. To test that possibility, we have to wait until the antibody that can recognize the endogeneous a protein in the tissues will be available. On the other hand, it is also the fact that staining of PEBP2b/CBFb was predominantly observed in the cytoplasm of most of the cells examined in this study, although a possibility is not excluded that the amount of PEBP2b/CBFb protein in the nuclei other than the multinucleated myotubes is undetectable by our immunohistochemical method. Furthermore, PEBP2b/ CBFb staining was mostly cytoplasmic as well in nonmyogenic cells or tissues (data not shown). What kind of function can be inferred for a cytoplasmic PEBP2b/ CBFb? One possibility is that PEBP2b/CBFb acts as a reservoir in the cytoplasm and waits for the expression of the a protein so that the ab heterodimer can function in the nucleus as a transcription factor. Another possibility is that the abundant accumulation in the cytoplasm may re¯ect an additional role for PEBP2b/CBFb. The present study demonstrates that the accumulation of PEBP2b/CBFb in the cytoplasm is dependent on the state of dierentiation of the myogenic cells and that it is colocalized with the aactinin molecules on or around the Z-lines in the muscle ®bers. We hypothesize that the cytoplasmic PEBP2b/CBFb may play some kind of architectural role inside the cells. In accordance with such a possibility, we recently observed that a fraction of the PEBP2b/CBFb protein in transfected REF52 cells shows colocalization with the actin-containing stress ®bers and membrane rues (YT and MS, unpublished observation).
A somewhat analogous situation as seen for PEBP2b/ CBFb is reported for a muscle LIM domain protein (MLP), a positive regulator of skeletal myogenesis (Arber et al., 1994) . This protein is located in the nuclei of dierentiating myotubes but relocates to the cytoplasm after cell maturation. In the case of an adhesion plaque protein called zyxin, the LIM domain is shown to function as a speci®c protein-binding interface (Schmeichel and Beckerle, 1994) . Another case is b-catenin. On the one hand, as a component of the adherens junction, the protein links the cadherin membrane protein to the cytoskeleton (Aberle et al., 1994; HuÈ lsken et al., 1994; McCrea et al., 1991; Nagafuchi et al., 1994) . On the other hand, as part of the Wnt-signaling pathway, the cytoplasmic b-catenin translocates to the nucleus by binding to a lymphoid enhancer-binding factor 1 (LEF-1) and alters the DNA binding activity of LEF-1 (Behrens et al., 1996; Huber et al., 1996) . Thus, how the dierential subcellular localization of PEBP2b/CBFb is related to possible distinct functions remains to be a challenge for future research. A more detailed analysis along these lines should help to fully elucidate the entire spectrum of roles played by the PEBP2b/CBFb protein in development, as well as in human acute myeloid leukemogenesis. 
Materials and methods
Antibodies
A multiple antigen peptide containing the amino-terminal ®fteen amino acid sequence of PEBP2b/CBFb (MPRVVPDQRSKFENE) was prepared by the Fmoc solid phase synthesis method (Tam, 1988) . Four hundred mg of the peptide suspended in distilled water was mixed with an equal volume of Freund's complete adjuvant (Difco) and the emulsion was injected subcutaneously into hens (white leghorn). A booster injection of 200 mg of the peptide mixed with Freund's incomplete adjuvant was given every 10 days and repeated four times. Blood was collected following each injection and the antibody titers of the sera were monitored by enzyme-linked immunosorbent assays with the peptide as antigenes. After a ®nal injection eggs were collected and the IgY fraction was puri®ed from egg yolk by ammonium sulfate and sodium sulfate precipitation and resuspended at a concentration of 11.3 mg/ml. Anti-peptide speci®c antibodies were puri®ed by passing 1 ml of a tenfold-diluted IgY fraction through an anity column consisting of 2.8 mg of the peptide linked to a 1 ml bed volume of cyanogen bromide-activated Sepharose 4B (Pharmacia). In a preabsorption experiment, 1 ml of appropriately-diluted (described below) anti-peptide antibody was incubated with 10 mg of the peptide on ice for 60 min prior to use in immunodetection. The preparation of the anti-PEBP2b/ Immunodetection of PEBP2b/CBFb in the heart and the digestive tract of embryos. Sections of E9.5 (a), E16.5 (b) or E13.5 (c) embryos were incubated with the anti-peptide antibody and processed for enzyme-linked immunodetection. a is a lower magni®ed view of the transverse section of the whole embryo. An arrow indicates the heart. The staining observed in the tissues other than the heart represent speci®c signals based on absorption of the antibody with the peptide. b and c are higher magni®ed views of the heart and digestive tract. In b, an arrow and an arrowhead indicate PEBP2b/CBFb positive and negative cells, respectively. In c, the muscularis mucosa is indicated by arrows Expression of PEBP2b/CBFb in muscle N Chiba et al
CBFb rabbit antiserum using the PEBP2b/CBFb protein puri®ed from an E. coli lysate was as described previously (Lu et al., 1995) .
Western blot (immunoblot) analysis
Proteins were extracted from E15.5 Balb/c mouse embryos using Isogen (Nippon Gene). In the case of a thigh muscle taken from adult mice or hind limbs from E16.5 embryos, 0.12 g of the tissue was homogenized in 400 ml of a solution containing 9 M urea, 2% (vol/vol) Triton X-100 and 1% (wt/vol) dithiothreitol. After adding 100 ml of 10% (wt/vol) lithium dodecyl sulfate and 6 ml of 1 M Tris-HCl, pH 7.4, the mixture was sonicated. Seventy-®ve mg of protein was added to each lane of a 0.1% (wt/vol) sodium dodecyl sulfate (SDS)-12% or 15% (wt/vol) polyacrylamide gel and the gel was subjected to electrophoresis. Proteins in the gel were transferred electrophoretically (at 85 mA for 2 h) onto a PVDF membrane (Bio Rad) in a buer of 25 mM 192mM glycine and 20% (vol/vol) methanol. The blocking reaction was done in 3% (wt/vol) skim milk in phosphate buered-saline (PBS) at 48C overnight. The membrane was incubated with agitation for 60 min in a 1000-fold-diluted anti-b peptide chick IgY solution in PBS containing 1% (wt/vol) bovine serum albumin. After six cycles of rinsing in PBS containing 0.05% (vol/vol) Tween 20 (PBS-T) for 10 min each, the membrane was incubated in a 3000-fold-diluted biotin-conjugated anti-chick IgY solution (Kirkegaard Perry Laboratories). In a dierent set of experiments, a 1000-fold-diluted anti-PEBP2b/CBFb rabbit serum (Lu et al., 1995) and a 3000-fold-diluted biotin-conjugated antirabbit IgG solution (Vector Laboratories, Inc.) were used. After rinsing in PBS-T, streptoavidin was coupled to biotin by using an ABC kit (Vector Laboratories). The membrane was rinsed in PBS-T and the proteins were visualized by immersing the membrane in an ECL detection reagent (Amersham) and exposing it to an X-ray ®lm (Fuji XR). For staining the gel, a quick-CBB staining solution (Wako Pure Chemical Industries, Ltd.) was used.
Immunohistochemistry
Tissues or embryos were excised from 8 week old male or pregnant female Balb/c mice, respectively. The tissues were ®xed in a PLP solution at 48C for 3 h. The PLP solution was 2% (wt/vol) paraformaldehyde, 75 mM L-lysine, 10 mM sodium metaperiodate and 37.5 mM phosphate buer, pH 7.4. After rinsing in PBS, the tissues were kept in a 20% (wt/vol) sucrose solution in PBS at 48C overnight. The tissues were immersed in an OCT compound (Miles) at 48C for 60 min. They were then rapidly frozen in an ethanol-liquid nitrogen bath and kept frozen at 7808C until use. The frozen tissues were sectioned into 5 to 15 mm thick slices using a cryostat (Leica) and air-dried for more than 90 min. The sections were treated with 0.3% (wt/vol) hydrogen peroxide in methanol for 30 min, followed by rinsing in PBS. The blocking reaction was done by incubating with a 10% (wt/vol) skim milk solution in PBS for 30 min. The sections were incubated with the primary antibody at 48C overnight. The antibodies used were 100-fold-diluted anity puri®ed anti-peptide chick antibody or 800-folddiluted anti-PEBP2b/CBFb rabbit serum. The antibodies were diluted in PBS containing 1% (wt/vol) bovine serum albumin. After rinsing in PBS to remove excess unbound antibody, the sections were incubated with the biotinylated secondary antibodies at 378C for 30 min. The secondary antibodies used were 100-fold-diluted anti-chick IgY antiserum or 1000-fold-diluted anti-rabbit IgG antiserum, respectively. Coupling of streptoavidin to biotin was carried out for 45 min by using an ABC kit. Immunocomplexes were revealed using a solution containing 0.3 mg/ml of 3,3'-diaminobenzidine, 0.65 mg/ml of NaN 3 , 0.006% (wt/vol) hydrogen peroxide, 50 mM Tris-HCl, pH 7.6 for 5 to 10 min. The reaction was stopped by rinsing in distilled water and the nuclei were counter-stained by methylgreen. The sections were dehydrated by passing through ethanol and cleared by treating with xylene three times. All the above procedures were carried out at room temperature unless indicated otherwise. The sections were mounted on microscopic slides with Permount (Fisher Scienti®c) and viewed through a Provis AX80T microscope (Olympus).
Double immuno¯uorescent staining of myo®brils
Myo®brils were prepared from a thigh muscle as follows. An 8 week old Balb/c mouse was sacri®ced and left for 30 min to induce postmortem rigidity. A thigh muscle along with attached bone was isolated and ®xed overnight at 48C in the PLP solution. The muscle was freed from the bone and homogenized by a Polytron in a buer containing 100 mM KCl, 5 mM EDTA and 39 mM boric acid buer, pH 7.1. The ratio of buer volume (ml) to muscle weight (g) was 5:1. The homogenate was centrifuged at 1000 r.p.m. for 3 min and the supernatant was collected. The supernatant was recentrifuged at 3000 r.p.m. for 3 min and the pellet suspended in a small volume of buer. The suspension was smeared onto microscopic slides and airdried.
The myo®brils on the slides were incubated with mixtures of 100-fold-diluted anity puri®ed anti-peptide chick antibody and 100-fold-diluted anti-a-actinin mouse monoclonal antibody (Biohit Oy). The secondary antibodies were mixtures of 100-fold-diluted FITC-conjugated antiserum directed against chick IgY and 100-fold-diluted RITCconjugated antiserum directed against mouse IgG (Organon Teknika Corp.). To double-label PEBP2b/CBFb and F-actin, the myo®brils were incubated with the anti-peptide antibody followed by the FITC-conjugated secondary antibody and 0.2 unit/ml of RITC-phalloidin (Molecular Probes, Inc.). The sample was viewed through a confocal laser scanning microscope (LSM410, Zeiss) with appropriate ®lters.
RNA extraction and Northern blotting
Freshly isolated tissues from 8 week old Balb/c mice were homogenized in solution D (4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% sarcosyl, 0.1 M 2-mercaptoethanol) by a Polytron and sonicated on ice. RNAs were extracted by the acid-guanidinium thiocyanatephenol-chloroform method (Chomczynski and Sacchi, 1987) . Poly(A) + RNAs were selected using Oligo (dT)-Latex (Takara). Two mg of poly(A) + RNA was separated on a 1% agarose gel containing 2.2 M formaldehyde and transferred to a Hybond N membrane (Amersham) in 206SSC (16SSC is 150 mM NaCl plus 15 mM sodium citrate). The probe was a DNA fragment (nt 1 to nt 1050) from Pebpb2 cDNA (Ogawa et al., 1993a) . The blot was hybridized with the 32 P-labeled probe (10 6 cpm/ml) in a mixture containing 50% formamide, 16Denhardt's solution, 1% SDS, 56SSC, 50 mM sodium phosphate, pH 7.0 and 100 mg per ml of denatured salmon sperm DNA at 428C for 16 h. The blot was washed twice in 0.16SSC, 0.1% SDS for 30 min at 658C and analysed using a Bio Imaging Analyzer (Fuji).
In situ hybridization histochemistry
The 817 bp fragment of Pebpb2 cDNA (nt 233 to nt 1050) (Ogawa et al., 1993a) which encompasses an open reading frame of the b2 isoform was subcloned into the XbaI site of the Bluescript pSK(+) in both orientations. The plasmids were linearized with BamHI and transcribed Expression of PEBP2b/CBFb in muscle N Chiba et al with T3 RNA polymerase to generate sense or antisense probes. Digoxigenin-11-UTP-labeled single-stranded RNA probes were prepared by using a DIG RNA labeling kit (Boehringer Mannheim GmbH Biochemica) according to the manufacturer's instructions. The methods of in situ hybridization including tissue preparation, sectioning, hybridization, washing and immunodetection of hybridized probes have been described previously in detail .
